Opportunity Information: Apply for PR PRP 13 001
Apply for PR PRP 13 001
- The CMS Consumer Information Insurance Oversight in the health sector is offering a public funding opportunity titled "Grants to States to Support Health Insurance Rate Review and Increase Transparency in Health Care Pricing, Cycle III" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.511 Affordable Care Act (ACA) Grants to States for Health Insurance Premium Review.
- This funding opportunity was created on Jul 9, 2013 and posted on May 8, 2013.
- Applicants must submit their applications by Aug 1, 2013 All grant applications must be submitted electronically and be received through http://www.grants.gov by 400 pm Eastern Daylight Time on the applicable due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $87,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $5,000,000.00 in funding.
- The number of recipients for this funding is limited to 57 candidate(s).
- Eligible applicants include: State governments.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The "Grants to States to Support Health Insurance Rate Review and Increase Transparency in Health Care Pricing, Cycle III" opportunity (Funding Opportunity Number PR PRP 13 001) is a discretionary federal grant program administered by the Centers for Medicare and Medicaid Services (CMS), specifically under the Consumer Information and Insurance Oversight area. It is tied to the Affordable Care Act program authority reflected in CFDA 93.511 (ACA Grants to States for Health Insurance Premium Review). The core purpose of the program is to strengthen states' ability to review proposed health insurance premium increases and to improve public transparency around health care pricing, with the broader aim of helping consumers, policymakers, and regulators better understand and respond to rising health care and insurance costs.
This Cycle III funding round anticipated up to 57 awards nationwide, indicating CMS intended broad state participation rather than a small pilot. The estimated total funding available was $87,000,000, with individual awards ranging from a floor of $500,000 to a ceiling of $5,000,000. The funding instrument is a grant, the activity category is health, and there is no cost-sharing or matching requirement, meaning states were not required to contribute non-federal funds as a condition of receiving an award.
Eligibility is limited to state governments. Practically, this means the applicants would be the relevant state entities that oversee insurance markets or consumer protection functions, such as state insurance departments or other designated state agencies. The program is designed to support state-level rate review functions, which typically include collecting insurer filings, analyzing the justification for premium increases, determining whether increases are unreasonable or not adequately supported, and communicating decisions and supporting information to the public. The emphasis on "increase transparency in health care pricing" signals that CMS also wanted states to invest in making pricing and rate information more accessible and understandable to consumers, which can include publishing rate review findings, improving public-facing reporting tools, and upgrading the systems used to collect, analyze, and disclose information.
The opportunity was posted on May 8, 2013, with an application deadline of August 1, 2013. Applications had to be submitted electronically through Grants.gov and received no later than 4:00 pm Eastern Daylight Time on the due date. The listing was archived on August 31, 2013, reflecting that it was a time-limited competition. For technical access issues with the full announcement or submission process, applicants were directed to the Grants.gov Contact Center (1-800-518-4726, support@grants.gov), which operates 24/7 except federal holidays.
In short, this grant competition offered substantial federal support for states to build or enhance the staffing, processes, and data capabilities needed to scrutinize health insurance premium increases and to provide clearer, more usable pricing information to the public. The combination of a large total funding pool, relatively high per-award ceilings, and no matching requirement suggests CMS aimed to accelerate state capacity quickly and encourage consistent, consumer-facing transparency practices across states.
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Grants to States to Support Health Insurance Rate Review and Increase Transparency in Health Care Pricing, Cycle III."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is PR PRP 13 001.
Who administers this grant program?
The program is administered by the Centers for Medicare and Medicaid Services (CMS), under the Consumer Information and Insurance Oversight area.
Is this a discretionary grant or a formula entitlement program?
This is a discretionary federal grant program, meaning funding is awarded through a competitive process rather than automatically by formula.
What federal program authority is associated with this opportunity?
The opportunity is tied to Affordable Care Act (ACA) program authority reflected in CFDA 93.511 (ACA Grants to States for Health Insurance Premium Review).
What is the main purpose of Cycle III funding?
The core purpose is to strengthen states' ability to review proposed health insurance premium increases and to improve public transparency around health care pricing. The broader aim is to help consumers, policymakers, and regulators better understand and respond to rising health care and insurance costs.
How many awards were anticipated under this cycle?
CMS anticipated up to 57 awards nationwide, suggesting an intent for broad state participation.
How much total funding was expected to be available?
The estimated total funding available was $87,000,000.
What was the minimum and maximum award size?
Individual awards ranged from a minimum (floor) of $500,000 to a maximum (ceiling) of $5,000,000.
What type of funding instrument is used?
The funding instrument is a grant.
What is the activity category for this opportunity?
The activity category is health.
Is there a cost-sharing or matching requirement?
No. There is no cost-sharing or matching requirement, meaning states were not required to contribute non-federal funds as a condition of receiving an award.
Who is eligible to apply?
Eligibility is limited to state governments.
Which state entities would typically apply for this funding?
Practically, applicants would be the relevant state entities that oversee insurance markets or consumer protection functions, such as state insurance departments or other designated state agencies.
What kinds of activities does the grant support related to insurance rate review?
The program is designed to support state-level rate review functions. These typically include collecting insurer filings, analyzing the justification for premium increases, determining whether increases are unreasonable or not adequately supported, and communicating decisions and supporting information to the public.
What does "increase transparency in health care pricing" mean in this grant context?
It signals that CMS wanted states to invest in making pricing and rate information more accessible and understandable to consumers. Examples mentioned include publishing rate review findings, improving public-facing reporting tools, and upgrading the systems used to collect, analyze, and disclose information.
When was the opportunity posted?
The opportunity was posted on May 8, 2013.
What was the application deadline?
The application deadline was August 1, 2013.
How were applications required to be submitted?
Applications had to be submitted electronically through Grants.gov.
What was the submission cutoff time on the deadline date?
Applications had to be received no later than 4:00 pm Eastern Daylight Time on the due date.
Is this opportunity still open?
No. The listing was archived on August 31, 2013, indicating it was a time-limited competition.
Where could applicants get help with technical issues related to accessing the announcement or submitting through Grants.gov?
Applicants were directed to the Grants.gov Contact Center at 1-800-518-4726 or support@grants.gov. The Contact Center operates 24/7 except federal holidays.
What is the overall intent behind offering a large funding pool with no matching requirement?
Based on the provided description, the combination of a large total funding pool, relatively high per-award ceilings, and no matching requirement suggests CMS aimed to accelerate state capacity quickly and encourage consistent, consumer-facing transparency practices across states.
Browse more opportunities from the same agency: CMS Consumer Information Insurance Oversight
Browse more opportunities from the same category: Health
Next opportunity: Rapid Threat Assessment (RTA)
Previous opportunity: 2013 Idaho BLM Noxious Weed Control Program
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PR PRP 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PR PRP 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| National Cooperative Reprogrammed Cell Research Groups (NCRCRG) to Study Mental Illness (U19) Apply for PAR 13 225 Funding Number: PAR 13 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improvement of Animal Models and Development of Technologies for Stem Cell Based Regenerative Medicine (SBIR)(R43/R44) Apply for PA 13 223 Funding Number: PA 13 223 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improvement of Animal Models and Development of Technologies for Stem Cell Based Regenerative Medicine (STTR)(R41/R42) Apply for PA 13 224 Funding Number: PA 13 224 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Mental Health Research Network II (U19) Apply for RFA MH 14 110 Funding Number: RFA MH 14 110 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Innovative Partnerships for Addressing Obesity through Environmental Supports for Nutrition and Physical Activity Apply for CDC RFA DP13 1304 Funding Number: CDC RFA DP13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Limited Competition Enhancing Investments in Comparative Effectiveness Research Resources (R01) Apply for RFA HS 13 011 Funding Number: RFA HS 13 011 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $750,000 |
| National Technical Assistance Resource Center for the Prevention of Sexual Violence Apply for CDC RFA CE13 1306 Funding Number: CDC RFA CE13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| SLEEP AND SLEEP DISORDER Apply for CDC RFA DP13 1306 Funding Number: CDC RFA DP13 1306 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| It Takes a Village Building State, Local, Tribal, and Territorial Partnerships for Community Preparedness and Response Apply for CDC RFA CE13 1308 Funding Number: CDC RFA CE13 1308 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Functional Glycomics in HIV Vaccine Design (R01) Apply for RFA AI 12 056 Funding Number: RFA AI 12 056 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Making Disasters Less Disastrous Public Health, Healthcare Executives, and Emergency Management Working Together Apply for CDC RFA CE13 1309 Funding Number: CDC RFA CE13 1309 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $200,000 |
| Pan American Health Organization (PAHO) Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas Apply for CDC RFA CK13 1301 Funding Number: CDC RFA CK13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Tribal Public Health Capacity Building and Quality Improvement Apply for CDC RFA OT13 1303 Funding Number: CDC RFA OT13 1303 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Coordinating Center for Access to Services for Children and Youths with Epilepsy Apply for HRSA 13 203 Funding Number: HRSA 13 203 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for State sponsored Youth Suicide Prevention and Early Intervention (Short Title State and Tribal Youth Suicide Prevention Grants) Apply for SM 13 010 Funding Number: SM 13 010 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $440,000 |
| STD Laboratory based Surveillance and Gonococcal Isolate Surveillance Project (GISP) Apply for CDC RFA PS14 1401 Funding Number: CDC RFA PS14 1401 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Fistual Prevention and Repair Project Apply for SOL OAA 13 000079 Funding Number: SOL OAA 13 000079 Agency: USAID Category: Health Funding Amount: $75,000,000 |
| Health Care Innovation Awards Round Two Apply for CMS 1C1 14 001 Funding Number: CMS 1C1 14 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $30,000,000 |
| Clinical Coordinating Center (CCC) for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network (U01) Apply for RFA HL 14 015 Funding Number: RFA HL 14 015 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network (U01) Apply for RFA HL 14 014 Funding Number: RFA HL 14 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PR PRP 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.